Analysts/Institutional Investor Meet/Con. Call Updates

Date:13October2026 Ref.No.:TCPCL/SEC/2026-27/00051 TheGeneralManager, TheManager, Corporaterelationshipdepartment, Listingdepartment, BSELimited NationalStockExchangeofIndiaLimited PhirozeJeejeebhoyTowers, ExchangePlaza,C-1,Block-G, DalalStreet,Fort, Bandra-KurlaComplex,Bandra(E), Mumbai-400001 Mumbai-400051 ScripCode:543321 ScripSymbol:TATVA Subject:IntimationofScheduleofEarningsCall DearSir/Madam, Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, we would like to inform you that the Earnings Call post announcement of financial results of the Company for the quarter and half year ended 30September2026,isscheduledonMonday,19October2026at05:00p.m.(IST). The Call is hosted by ICICI Securities and an invite in this regard is attached for your informationandrecords. The above information is also being made available on the website of the Company at www.tatvachintan.com. Kindlytaketheaboveintimationonyourrecordandoblige. Thankingyou, Yoursfaithfully, ForTatvaChintanPharmaChemLimited IshwarNayi CompanySecretaryandComplianceOfficer M.No.:A37444 Encl.:Asabove is pleased to invite you to the Q2FY27 Results Conference Call Tatva Chintan Pharma Chem Limited Represented by Mr. Chintan Shah, Managing Director Mr. Ajesh Pillai, Chief Financial Officer Monday, October 19, 2026 at 17:00 hrs India Time Diamond Pass registration link: Copy this Link in your browser: Link Call Co-ordinator: Mr. Sanjesh Jain: Phone: +91 22 6807 7153, e-mail: sanjesh.jain@icicisecurities.com Mr. Mohit Mishra: Phone: +91 22 6807 7637, e-mail: mohit.mishra@icicisecurities.com For any clarification, please contact: Mr. Rushad Kapadia: Phone: +91 22 6807 7334, e-mail: rushad.Kapadia@icicisecurities.com Ms. Seema Sehgal: Phone: +91 9871116926, e-mail: seema.sehgal@icicisecurities.com Ms. Minali Ginwala: Phone: +91 22 6807 7454, e-mail: minali.ginwala@icicisecurities.com